Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: Confirmation in a Hungarian sample

Molecular Psychiatry

Volumn 10, Issue 9, 2005, Pages 861-867

  Strauss, J ^a,h   Barr, C L ^b,c   George, C J ^d   Devlin, B ^d   Vetro A ^e   Kiss, E ^e   Baji, I ^f   King, N ^a   Shaikh, S ^a   Lanktree, M ^a   Kovacs, M ^d,g   Kennedy, J L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF SZEGED   (Hungary)

^f Vadaskert Hospital   (Hungary)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Childhood onset; Genetic association; Haplotype; Mood disorder; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ALLELE; ARTICLE; CHILDHOOD; CONTROLLED STUDY; DYSTHYMIA; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AMINO ACID SUBSTITUTION; CHILD; ETHNOLOGY; GENETIC MARKER; GENETIC VARIABILITY; GENETICS; HOMOZYGOTE; REPRODUCIBILITY; UNITED STATES;

ADULT; AGE OF ONSET; AMINO ACID SUBSTITUTION; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; GENETIC MARKERS; HOMOZYGOTE; HUMANS; HUNGARY; MOOD DISORDERS; PENNSYLVANIA; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; VARIATION (GENETICS);

EID: 27744498029     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001685     Document Type: Article

References (49)

1. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386-392.
2. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J, Dahl RE et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry 1996; 35: 1427-1439.
3. Kovacs M. Depressive disorders in childhood: an impressionistic landscape. J Child Psychol Psychiatry 1997; 38: 287-298.
4. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552-1562.
5. Rice F, Harold G, Thapar A. The genetic aetiology of childhood depression: a review. J Child Psychol Psychiatry 2002; 43: 65-79.
6. Todd RD, Botteron KN. Family, genetic, and imaging studies of early-onset depression. Child Adolesc Psychiatr Clin N Am 2001; 10: 375-390.
7. Todd RD, Neuman R, Geller B, Fox LW, Hickok J. Genetic studies of affective disorders: should we be starting with childhood onset probands? J Am Acad Child Adolesc Psychiatry 1993; 32: 1164-1171.
8. Neuman RJ, Geller B, Rice JP, Todd RD. Increased prevalence and earlier onset of mood disorders among relatives of prepubertal vs adult probands. J Am Acad Child Adolesc Psychiatry 1997; 36: 466-473.
9. Duman RS. Genetics of childhood disorders: XXXIX. Stem cell research, Part 3: regulation of neurogenesis by stress and antidepressant treatment. J Am Acad Child Adolesc Psychiatry 2002; 41: 745-748.
10. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
11. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev 2004; 45: 104-114.
12. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. PNAS USA 1996; 93: 3908-3913.
13. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516-1518.
14. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 2001; 50: 260-265.
15. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
16. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
17. Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 261-265.
18. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA 1999; 96: 5604-5609.
19. McInnes LA, Escamilla MA, Service SK, Reus VI, Leon P, Silva S et al. A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci USA 1996; 93: 13060-13065.
20. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-269.
21. Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24: 10099-10102.
22. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002; 71: 651-655.
23. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry 2002; 7: 579-593.
24. Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186-189.
25. Kunugi H, Iijima Y, Tatsumi M, Yoshida M, Hashimoto R, Kato T et al. No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study. Biol Psychiatry 2004; 56: 376-378.
26. Nakata K, Ujike H, Sakai A, Uchida N, Nomura A, Imamura T et al. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci Lett 2003; 337: 17-20.
27. Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005; 10: 208-212.
28. Oswald P, Del-Favero J, Massat I, Souery D, Claes S, van Broeckhoven E. Non-replication of the brain-derived neurotrophic factor (BDNF) association in bipolar affective disorder: a Belgian patient-control study. Am J Med Genet 2004; 129B: 34-35.
29. Skibinska M, Hauser J, Czerski PM, Leszczynska-Rodziewicz A, Kosmowska M, Kapelski P et al. Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder. World J Biol Psychiatry 2004; 5: 215-220.
30. Lang UE, Hellweg R, Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004; 29: 795-798.
31. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T et al. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 2005; 26, [Epub ahead of print].
32. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003; 28: 397-401.
33. Tsai SJ, Hong CJ, Yu YW, Chen TJ. Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females. Neuropsychobiology 2004; 49: 13-16.
34. Strauss J, Barr CL, George CJ, King N, Shaikh S, Devlin B et al. Association study of brain-derived neurotrophic factor in adults with a history of childhood-onset mood disorder. Am J Med Genet (Neuropsychiatr Genet) 2004; 131B: 16-19.
35. Sherrill JT, Kovacs M. Interview schedule for children and adolescents (ISCA). J Am Acad Child Adolesc Psychiatry 2000; 39: 67-75.
36. Lahiri DK, Nurnberger Jr JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
37. Liu QR, Walther D, Drgon T, Polesskaya O, Lesnick TG, Strain KJ et al. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B (Neuropsychiatr Genet) 2005; 134: 93-103.
38. Proschel M, Saunders A, Roses AD, Muller CR. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum Mol Genet 1992; 1: 353.
39. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
40. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum Hered 2000; 50: 211-223.
41. Zhao JH. 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 2004; 20: 1325-1326.
42. Rinaldo A, Bacanu S-B, Devlin B, Sonpar V, Wasserman L, Roeder K. Characterization of multilocus linkage disequilibrium. Genet Epidemiol 2005; 28: 193-206.
43. Seltman H, Roeder K, Devlin B. Evolutionary-based association analysis using haplotype data. Genet Epidemiol 2003; 25: 48-58.
44. Crandall KA, Templeton AR. Empirical tests of some predictions from coalescent theory with applications to intraspecific phylogeny construction. Genetics 1993; 134: 959-969.
45. Geller B, Badner JA, Tillman R, Christian SL, Bolhofner K, Cook Jr EH. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004; 161: 1698-1700.
46. Hariri AR, Goldberg TE, Mattay VS, Kolachana BS, Callicott JH, Egan MF et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003; 23: 6690-6694.
47. Seltman H, Roeder K, Devlin B. Transmission/disequilibrium test meets measured haplotype analysis: family-based association analysis guided by evolution of haplotypes. Am J Hum Genet 2001; 68: 1250-1263.
48. Roeder K, Bacanu S-B, Sonpar V, Zhang X, Devlin B. Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 2005; 6 [Epub ahead of print].
49. Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003; 73: 370-376.